What is MaRS EXCITE?
The MaRS Excellence in Clinical Innovation Technology Evaluation (EXCITE) program is a part of the MaRS Health portfolio. We believe that innovations in heath technology can significantly improve the care and well-being of patients everywhere and drive economic growth for Ontario. We work to break down the barriers between the health system and technology innovators to effect health system change.
Before taking their product to market, health technology innovators typically invest resources into testing their technology. Often, the results are sufficient enough to get licensing and regulatory approval, but not enough to show the value of the technology and convince the health system to invest and adopt it.
EXCITE connects health technology innovators with experienced, award-winning researchers to get the right evidence and data they need to show the value of their product and facilitates discussions with relevant health system stakeholders to determine what it takes to get their technology adopted successfully.
At the end of the program, companies will have:
- a robust evidence package, called the EXCITE core evidentiary bundle, that they can use for both regulatory or licensing approval and reimbursement and purchasing reviews
- experience connecting with the health system and relevant feedback concerning conditions needed for successful adoption of their technology
MaRS EXCITE will be hosting an information session with Q&A on February 18, 2016 from 3:00 pm – 4:00 pm. Register for the information session.
Applications to EXCITE are accepted throughout the year. The next review period will start February 25. Please visit the “How to Apply to EXCITE” page for more details.